FdaApplication
BLA 125085
Identifiers
- fda_app_no: BLA125085
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2004-02-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AVASTIN | BEVACIZUMAB | 100MG/4ML (25MG/ML) | VIAL;INTRAVENOUS |
| AVASTIN | BEVACIZUMAB | 400MG/16ML (25MG/ML) | VIAL;INTRAVENOUS |
2 products